Abstract
In Reply. —We wish to respond to certain elements in the accompanying LETTERS TO THE EDITOR by Hoogenraad and Van Hattum and by Pall and coworkers concerning our recent article in theArchives.1 Hoogenraad and Van Hattum say would have been better to start treatment with in the patient in the case report, and is difficult to understand why Brewer and coworkers waited so long to switch over to zinc therapy. We made it clear in the article that the patient had been started on penicillamine by other physicians and the patient was not referred to us until six weeks after therapy had been initiated. As we said in the article, we did not switch the patient over to zinc therapy at that point, because we believed that the patient had already been through the syndrome of neurologic worsening from penicillamine. As our data show in theArchives
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
